Sun BioPharma Research, Inc. — Form D

Sun BioPharma Research, Inc. of Waconia, MN, a company, filed a Form D exempt-offering notice with the SEC on 2015-09-17. The offering totals $1.2M, of which $1.2M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (22)

NameRoleLocation
Michael T CullenDirectorWaconia, MN
Suzanne X GagnonDirectorWaconia, MN
David B KaysenDirectorWaconia, MN
Thomas X NeenanDirectorBoston, MA
Paul W SchafferDirectorWaconia, MN
Donald R SchemelDirectorWaconia, MN
Michael T CullenExecutive OfficerWaconia, MN
Suzanne X GagnonExecutive OfficerWaconia, MN
David B KaysenExecutive OfficerWaconia, MN
Thomas X NeenanExecutive OfficerBoston, MA
Daniel E RyweckExecutive OfficerWaconia, MN
D. ROBERT SCHEMELDirectorWACONIA, MN
Jeffrey R HarderDirectorHouston, TX
Clifford F McCurdy, IIIDirectorPonte Vedra Beach, FL
Clifford F McCurdy, IIIExecutive OfficerPonte Vedra Beach, FL
Randall L JohnsonExecutive OfficerMinnetonka, MN
Douglas M PolinskyDirectorWayzata, MN
Douglas M PolinskyExecutive OfficerWayzata, MN
Ryan R GilbertsonExecutive OfficerDelano, MN
Christopher R JohnsonExecutive OfficerEden Prairie, MN
Paul M HerronDirectorPonte Vedra Beach, FL
Paul M HerronExecutive OfficerPonte Vedra Beach, FL

Other filings by this issuer (4)

FiledFormOfferingSold
2014-02-04D$6.0M$3.1M
2013-06-28D/A$2.3M$2.3M
2013-05-23D$2.0M$900K
2012-03-12D$2.0M$549K

More